| Released | Contributor | Author | Title | Pages | Price |
|---|
| May 17, 2013 | Reuters Investment Profile | N/A | ImmunoCellular Therapeutics Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 | $138 | | May 16, 2013 | Thomson Reuters Stock Report | StockReports + Research Department | Thomson Reuters Stock Report - IMMUNOCELLULAR THERAPEUTICS LTD. (IMUC-A) | 11 | $25 | | May 16, 2013 | ValuEngine, Inc. | N/A | ValuEngine Industry Report for Medical-biomed/genetics | 18 | $207 | | May 16, 2013 | Ford Investor Services, Inc. | N/A | Value Graph: IMMUNOCELLULAR -- IMUC | 1 | $11.50 | | May 16, 2013 | Ford Investor Services, Inc. | N/A | Industry Value Graph: ACOR , AFFY , BSTC , IMUC , TELK -- DRUGS | 3 | $34.50 | | May 15, 2013 | ValuEngine, Inc. | N/A | ValuEngine Detailed Valuation Report for IMUC | 11 | $126.50 | | May 9, 2013 | Streetwise Reports | Jason Kolbert | Position Yourself for Big Returns in the Stem Cell Space: Jason Kolbert | 10 | $92 |
|
View All Reports for IMUC ... |
|
|
0.80%